Website profile

Yahoo Finance

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

  • 282,908articles · 365d
  • 3+ hour agolatest article
  • Sep 14, 2025earliest in window
  • 9%with images · 12,369 videos
  • 293avg words
articles per day
Categories
  • Economy, Business & Finance 248,565
  • Finance & Business 235,381
  • News 129,671
  • Finance 70,345
  • Business & Industrial 29,091
  • Health & Wellness 11,548
  • Science & Technology 9,391
  • Medical 8,069

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Yahoo Finance
finance.yahoo.com > media-advertising > articles > laifen-closes-loop-beauty-routine-070000249.html

Laifen Closes the Loop on the Beauty Routine with Three New Innovations Completing Its At-Home Beauty Ecosystem

1+ week, 6+ day ago   (236+ words) Introducing the Swift 4 High-Speed Hair Dryer, AutoCurl Curling Iron and Glowy Vanity Mirror to Complete the Hair-to-Beauty Ritual NEW YORK, Sept. 1, 2026 /PRNewswire/ -- Laifen, the global personal care technology brand known for redefining the hair dryer through high-speed performance and thoughtful…...

Yahoo Finance
finance.yahoo.com > healthcare > articles > celcuity-announces-fda-approval-revtorpyk-205300623.html

Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer

1+ mon, 4+ week ago   (468+ words) REVTORPYK is the first and only FDA-approved therapy that inhibits all class I PI3K isoforms (α, β, δ, γ) and mTOR complexes mTORC1 and mTORC2 In the Phase 3 VIKTORIA-1 trial, REVTORPYK combined with palbociclib and fulvestrant and REVTORPYK combined with fulvestrant reduced the…...

Yahoo Finance
finance.yahoo.com > healthcare > articles > hair-removal-method-predates-laser-103300702.html

The Hair Removal Method That Predates Laser Is Now the One Some NYC Clients Can't Find Anywhere Else

1+ mon, 4+ week ago   (496+ words) Why Laser Has a Blind Spot Laser hair removal has transformed the industry and remains highly effective for clients with sufficient contrast between hair color and skin tone. The technology targets melanin, the pigment that gives hair its color, using…...

Yahoo Finance
finance.yahoo.com > small-business > articles > choice-van-line-highlights-independent-163800502.html

Choice Van Line Highlights Independent Customer Reviews as Consumers Research Long-Distance Moving Companies

2+ mon, 1+ week ago   (198+ words) Choice Van Line operates as a licensed and insured interstate moving carrier serving residential and commercial customers throughout the continental United States. By working directly with customers from the initial estimate through final delivery, the company focuses on providing consistent…...

Yahoo Finance
finance.yahoo.com > news > rise-advanced-maternal-age-ivf-114100176.html

The Rise of Advanced Maternal Age IVF: BaseCare Medical'-B(2170.HK) AI "Undisturbed Culture" Empowers Intelligent Assisted Reproduction

9+ mon, 3+ week ago   (203+ words) SUZHOU, China, Nov. 19, 2025 /PRNewswire/ -- Data from the keynote report at the 18th Annual Conference of the Chinese Society of Reproductive Medicine (CSRM2025), held from November 12th to 15th, indicates that the average treatment age for women undergoing IVF in China has risen to 33.6 years,…...

Yahoo Finance
finance.yahoo.com > news > medsir-ataraxis-ai-launch-research-130000710.html

MEDSIR and Ataraxis AI Launch Research Collaboration to Evaluate AI-Powered Platform as a Predictive Tool in Breast Cancer Randomized Clinical Trials

11+ mon, 1+ week ago   (656+ words) NEW YORK, October 02, 2025--Ataraxis AI, a frontier laboratory developing artificial intelligence (AI)–powered prognostic tools for oncology, and MEDSIR (Medica Scientia Innovation Research), a global leader in oncology research, today announced a strategic collaboration to integrate artificial intelligence into multiple…...